These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 866739)

  • 41. Changing concepts on the control of growth hormone secretion in man.
    VanderLaan WP
    Calif Med; 1971 Aug; 115(2):38-46. PubMed ID: 4935302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L-dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male rats.
    Sonntag WE; Forman LJ; Miki N; Trapp JM; Gottschall PE; Meites J
    Neuroendocrinology; 1982 Mar; 34(3):163-8. PubMed ID: 6122169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma free fatty acid concentrations in Houssay dogs following a single injection of growth hormone.
    Sirek OV; Sirek A; Przybylska K; Doolan H; Niki A
    Endocrinology; 1967 Aug; 81(2):395-7. PubMed ID: 4952014
    [No Abstract]   [Full Text] [Related]  

  • 44. Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
    Molinatti GM; Camanni F; Massara F; Isaia GC
    Panminerva Med; 1975 Apr; 17(4):101-6. PubMed ID: 1153217
    [No Abstract]   [Full Text] [Related]  

  • 45. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M; Jurcovicová J; Németh S; Vigas M
    Endocrinol Exp; 1988 Dec; 22(4):243-8. PubMed ID: 3243205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children.
    Ghigo E; Bellone J; Imperiale E; Arvat E; Mazza E; Valetto MR; Boffano GM; Cappa M; Loche S; De Sanctis C
    Neuroendocrinology; 1990 Jul; 52(1):42-5. PubMed ID: 1697660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
    Camanni F; Massara F; Fassio V; Molinatti GM; Müller EE
    Neuroendocrinology; 1975; 19(3):227-40. PubMed ID: 1223659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P; Enjaume P; Dutau G; Ribot C; Augier D
    Arch Fr Pediatr; 1976 Jan; 33(1):55-66. PubMed ID: 985031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Action of L-dopa and dopamine on plasma free fatty acids in normal and obese subjects].
    Balestreri R; Barreca T; Marcenaro A; Valice S
    Boll Soc Ital Biol Sper; 1975 May; 51(9-10):614-20. PubMed ID: 1203133
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of 1-dihydroxyphenylalanine (l-dopa), anesthesia and surgical stress on the secretion of growth hormone in the dog.
    Lovinger RD; Connors MH; Kaplan SL; Ganong WF; Grumbach MM
    Endocrinology; 1974 Nov; 95(5):1317-21. PubMed ID: 4426291
    [No Abstract]   [Full Text] [Related]  

  • 51. [3,5-Dimethylisoxazole and exogenously stimulated lipolysis. 1. Influence of 3,5-dimethylisoxazole on adrenaline and human growth hormone increased levels of fatty acids in the plasma and of the blood sugar].
    Tragl KH; Geyer G
    Arzneimittelforschung; 1970 Nov; 20(11):1806-8. PubMed ID: 5536998
    [No Abstract]   [Full Text] [Related]  

  • 52. [Growth hormone secretion in patients with various types of diabetes mellitus and in healthy persons after L-dopa stimulation].
    Muszyński J
    Pol Arch Med Wewn; 1983; 69(4-5):341-50. PubMed ID: 6634455
    [No Abstract]   [Full Text] [Related]  

  • 53. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS; Jacobs LS
    J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey.
    Diefenbach WP; Carmel PW; Frantz AG; Ferin M
    J Clin Endocrinol Metab; 1976 Sep; 43(3):638-42. PubMed ID: 821963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Free fatty acids suppress growth hormone, but not luteinizing hormone, secretion in sheep.
    Estienne MJ; Schillo KK; Green MA; Boling JA
    Endocrinology; 1989 Jul; 125(1):85-91. PubMed ID: 2544416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly].
    Fossati P; Asfour M; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Brion-Brevan B
    Lille Med; 1976 Nov; 19(9):757-65. PubMed ID: 1004102
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients.
    Dobrew D; Zonew I; Milanow S
    Ther Hung; 1977; 25(4):145-9. PubMed ID: 605413
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter: Enhancement of levodopa-induced growth-hormone stimulation by practolol.
    Lotti G; Delitala G; Masala A
    Lancet; 1974 Nov; 2(7892):1329. PubMed ID: 4139577
    [No Abstract]   [Full Text] [Related]  

  • 59. Influence of exogenous growth hormone on endogenous growth hormone release.
    Müller E; Pecile A
    Proc Soc Exp Biol Med; 1966; 122(4):1289-91. PubMed ID: 5918153
    [No Abstract]   [Full Text] [Related]  

  • 60. [Evaluation of pituitary function by clinical bio-chemical assays].
    Norman N
    Tidsskr Nor Laegeforen; 1972 Nov; 92(32):2160-6. PubMed ID: 4657008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.